Helping Your Patients Access Ritonavir

For patients on boosted protease inhibitor regimens or those prescribed Paxlovid, a gap in Ritonavir supply can disrupt treatment at a critical time. As a provider, you're often the first person a patient calls when they can't fill their prescription.

This guide outlines practical steps you and your care team can take to help patients find Ritonavir, navigate cost barriers, and maintain treatment continuity.

Current Ritonavir Availability

As of 2026, Ritonavir is not in official shortage. Generic 100 mg tablets are available from multiple manufacturers, and supply has stabilized significantly since the Paxlovid-driven demand spikes of 2022.

However, availability gaps can still occur because:

• Retail chain pharmacies may not stock HIV medications unless they have regular demand.
• The oral solution (80 mg/mL) and oral powder (100 mg packets) have more limited distribution channels.
• Insurance or specialty pharmacy restrictions may limit where patients can fill.
• Regional distribution differences mean some areas have better stock than others.

Why Patients Can't Find Ritonavir

Understanding the root cause helps you direct patients effectively:

• "My pharmacy doesn't carry it": Most common reason. The pharmacy simply doesn't stock it. Direct to specialty pharmacy or use Medfinder.
• "My insurance won't cover it there": Plan requires specialty pharmacy or has preferred pharmacy restrictions. Review formulary or contact plan.
• "I can't afford the copay": Cost barrier. Connect with ADAP, manufacturer assistance, or discount cards.
• "They said it's on backorder": Temporary supply issue with their distributor. Try alternate pharmacies or formulations.

What Providers Can Do: 5 Steps

Step 1: Recommend Medfinder

Direct patients to Medfinder, a free real-time pharmacy stock checker. Patients enter their medication and zip code to see which nearby pharmacies currently have Ritonavir in stock. This eliminates the time-consuming process of calling pharmacies one by one.

Consider posting Medfinder information in your clinic's patient resources or discharge instructions.

Step 2: Connect With Specialty Pharmacies

For patients on HIV regimens, specialty pharmacies are typically the most reliable Ritonavir source. Benefits include:

• Consistent stock of antiretrovirals
• Insurance coordination and prior authorization support
• Adherence monitoring and patient education
• Home delivery options

If your practice doesn't have an established specialty pharmacy relationship, your health system's pharmacy department can help identify options.

Step 3: Facilitate ADAP Enrollment

For uninsured or underinsured patients, the AIDS Drug Assistance Program (ADAP) covers the full cost of Ritonavir. Key points:

• Every state has an ADAP program — eligibility varies but generally covers individuals at or below 300-500% of the federal poverty level.
• Enrollment requires HIV diagnosis, income documentation, and state residency.
• Your clinic's social worker or case manager can assist with applications.
• The HarborPath program provides bridge coverage for patients on ADAP waiting lists.

Step 4: Explore Alternative Formulations or Boosters

If a specific Ritonavir formulation is unavailable:

• Switch formulation: If tablets are unavailable, the oral solution or powder may be accessible (or vice versa). Adjust prescribing accordingly.
• Substitute Cobicistat: For patients using Ritonavir solely as a pharmacokinetic booster, Cobicistat (Tybost) is a clinically equivalent alternative. Available standalone or in combination products (Prezcobix, Stribild).
• Consider regimen change: For appropriate candidates, transitioning to an INSTI-based regimen (Biktarvy, Dovato) eliminates booster dependence entirely.

Step 5: Use E-Prescribing Flexibility

If a patient's pharmacy is out of stock:

• Send a new e-prescription to a pharmacy with confirmed stock (patient can check via Medfinder).
• For urgent situations, call in a short bridge supply to a pharmacy that has stock while the regular pharmacy orders.
• Document pharmacy availability issues in the patient's chart to inform future prescribing decisions.

Alternative Medications

When Ritonavir isn't available or isn't the best fit, consider:

• Cobicistat (Tybost): CYP3A4 inhibitor for boosting. No intrinsic antiviral activity. Similar interaction profile with key differences (no effect on CYP2D6).
• Lopinavir/Ritonavir (Kaletra): Fixed-dose combination. Contains ritonavir but in a different supply chain — may be available when standalone Ritonavir is not.
• Biktarvy, Dovato, Cabenuva: Booster-free INSTI-based regimens. Increasingly preferred as first-line. Consider for treatment simplification.

See our alternatives guide for a patient-friendly version you can share.

Workflow Tips for Your Practice

• Proactive refill monitoring: Track refill dates for patients on boosted PI regimens. Reach out 7-10 days before refill is due to identify potential stock issues early.
• Formulary awareness: Maintain a current list of which plans require specialty pharmacy for HIV medications and which specialty pharmacies stock Ritonavir.
• Patient education handout: Create a one-page resource with Medfinder, ADAP contact information, and steps for patients to follow if they can't find their medication.
• Clinic-pharmacy communication: Establish direct lines with 2-3 pharmacies (including at least one specialty pharmacy) for quick stock checks and priority ordering.

Final Thoughts

While Ritonavir supply has largely stabilized, individual patients can still face access barriers. A proactive approach — combining tools like Medfinder, ADAP enrollment, specialty pharmacy relationships, and clinical flexibility around alternatives — can keep your patients on track.

For the latest on supply status, see our Ritonavir shortage briefing for providers.